Regeneron Pharmaceuticals (REGN)

Income Before Tax

$5.17B

TTM · Period ending: · USD

REGN logo

REGN Income Before Tax

Latest reported$5.17B
REGN TTM Pre-Tax Income ($0.00 → $5.17B)
High-resolution chart · PNG

REGN income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
5,166,000,000
5,156,900,000
5,230,700,000
5,145,100,000
4,874,800,000
4,984,200,000
4,779,900,000
4,969,400,000
4,587,200,000
4,042,000,000
4,199,300,000
4,376,400,000
4,775,400,000
4,655,700,000
4,858,800,000
6,037,500,000
6,344,300,000
9,133,900,000
9,325,800,000
8,047,000,000
7,228,700,000
4,394,800,000
3,810,400,000
3,475,600,000
3,245,800,000
2,551,600,000
2,429,100,000
2,215,500,000
2,082,861,000
2,514,235,000
2,553,533,000
2,432,100,000
2,361,844,000
2,231,620,000
2,078,511,000
1,865,271,000
1,665,547,000
1,431,953,000
1,329,815,000
1,215,577,000
1,242,985,000
1,278,725,000
1,225,097,000
1,219,095,000
1,001,884,000
877,007,000
775,747,000
752,613,000
802,219,000
746,792,000
713,360,000
649,766,000
615,550,000
544,601,000
414,421,000
225,804,000
-27,467,000
-167,578,000
-222,892,000
-183,431,000
-153,269,000
-113,033,000
-99,674,000
-125,688,000
-95,062,000
-86,868,000
-74,045,000
-65,680,000
-82,701,000
-83,548,000
-74,674,000
-52,489,000
-67,280,000
-75,258,000
-93,557,000
-186,646,000
-181,229,000
-183,172,000
-156,266,000
169,065,000
164,834,000
166,552,000
165,442,000
-52,765,000
-29,186,000
-16,736,000
52,042,000
31,797,000
15,441,000
1,148,000
-93,691,000
-110,320,000
-115,701,000
-117,266,000
-112,518,000
-105,469,000
-95,561,000
-82,956,000
-70,751,000
-61,502,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.